Nancy A. ElNaker

Nancy A. ElNaker

Auto-generated profile, based on publicly available information

Nancy A. ElNaker

Affiliation Department of Chemistry, Khalifa University, Abu Dhabi, United Arab Emirates

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Mariane DaouMariane Daou
Mariane Daou
NENancy A. Elnaker
Nancy A. Elnaker
MOMichael A. Ochsenkühn
Michael A. Ochsenkühn
SAShady A. Amin
Shady A. Amin
AYAhmed F. Yousef
Ahmed F. Yousef
LYLina Yousef
Lina Yousef
α-glucosidase inhibitors represent an important class of type 2 antidiabetic drugs and they act by lowering postprandial hyperglycemia. Today, only three synthetic inhibitors exist on the market, and there is a need for novel, natural and more efficient molecules exhibiting this activity. In this study, we investigated the ability of Tamarix nilotica ethanolic and aqueous shoot extracts, as well as methanolic fractions prepared from aqueous crude extracts to inhibit α-glucosidase. Both, 50% ethanol and aqueous extracts inhibited α-glucosidase in a concentration-dependent manner, with IC50 values of 12.5 μg/mL and 24.8 μg/mL, respectively. Importantly, α-glucosidase inhibitory activity observed in the T. nilotica crude extracts was considerably higher than pure acarbose (IC50 = 151.1 μg/mL), the most highly prescribed α-glucosidase inhibitor on the market. When T. nilotica crude extracts were fractionated using methanol, enhanced α-glucosidase inhibitory activity was observed in general, with the highest observed α-glucosidase inhibitory activity in the 30% methanol fraction (IC50 = 5.21 μg/mL). Kinetic studies further revealed a competitive reversible mechanism of inhibition by the plant extract. The phytochemical profiles of 50% ethanol extracts, aqueous extracts, and the methanolic fractions were investigated and compared using a metabolomics approach. Statistical analysis revealed significant differences in the contents of the crude extracts and fractions and potentially identified the molecules that were most responsible for these observed variations. Higher α-glucosidase inhibitory activity was associated with an enrichment of terpenoids, fatty acids, and flavonoids. Among the identified molecules, active compounds with known α-glucosidase inhibitory activity were detected, including unsaturated fatty acids, triterpenoids, and flavonoid glycosides. These results put forward T. nilotica as a therapeutic plant for type 2 diabetes and a source of α-glucosidase inhibitors.

25 May 2020 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
NENancy A. ElNaker
Nancy A. ElNaker
AYAhmed F. Yousef
Ahmed F. Yousef
LYLina F. Yousef
Lina F. Yousef